84P Adebrelimab plus chemotherapy (chemo) as first-line treatment for extensive-stage small-cell lung cancer (ES-SCLC): 3-year update of the phase III CAPSTONE-1 study
Autor: | Cheng, Y., Wang, J., Zhou, C., Yao, W., Wang, Q-M., Min, X., Chen, G., Xu, X., Li, X-Y., Xu, F., Fang, Y., Yang, R., Yu, G., Gong, Y., Zhao, J., Fan, Y., Liu, Q., Cao, L., Li, X., Ma, K. |
---|---|
Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
Databáze: | ScienceDirect |
Externí odkaz: |